Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2-Reference-Cited by-同舟云学术

Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2

Published:2019-09-08 Issue:12 Volume:8 Page:1661194
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Troschke-Meurer Sascha¹^ORCID,Siebert Nikolai¹,Marx Madlen¹^ORCID,Zumpe Maxi¹,Ehlert Karoline¹,Mutschlechner Oliver²,Loibner Hans²,Ladenstein Ruth³,Lode Holger N.¹^ORCID

Affiliation:

1. Department of Pediatric Oncology and Hematology, University Medicine Greifswald, Greifswald, Germany

2. HL Bioscience Research GmbH, Vienna, Austria

3. St. Anna Children‘s Hospital and Children’s Cancer Research Institute (CCRI), Department of Pediatrics, Medical University, Vienna, Austria

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1661194

Reference53 articles.

1. Overview and recent advances in the treatment of neuroblastoma